We are live on ! Find out more
BSX icon

Boston Scientific

1,058 hedge funds and large institutions have $70.6B invested in Boston Scientific in 2023 Q3 according to their latest regulatory filings, with 98 funds opening new positions, 441 increasing their positions, 352 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital inflows, than outflows

Capital inflows: $4.3B | Capital outflows: $3.37B

25% more repeat investments, than reductions

Existing positions increased: 441 | Existing positions reduced: 352

4% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 94

0.73% more ownership

Funds ownership: 90.66% → 91.38% (+0.73%)

1% less funds holding

Funds holding: 1,068 → 1,058 (-10)

3% less funds holding in top 10

Funds holding in top 10: 30 → 29 (-1)

18% less call options, than puts

Call options by funds: $426M | Put options by funds: $520M

Holders
1,058
Holders Change
-10
Holders Change %
-0.94%
% of All Funds
16.75%
Holding in Top 10
29
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-3.33%
% of All Funds
0.46%
New
98
Increased
441
Reduced
352
Closed
94
Calls
$426​M
Puts
$520​M
Net Calls
-⁠$93.5​M
Net Calls Change
-⁠$62.7​M

BSX Hedge Fund Activity: Q3 2023 in Review

1,058 of the 6,318 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2023, worth a combined $70.6B — down 1.4% from $71.6B a quarter earlier.

Buyers outnumbered sellers: 98 funds opened new BSX positions and 94 closed out — a net gain of 4 holders — while 441 added to existing stakes and 352 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $422M. The largest seller was BlackRock, cutting an estimated $429M.

  • 1,058 institutional investors held Boston Scientific (BSX) as of Q3 2023, down from 1,068 in Q2 2023.
  • Funds reported $70.6B of Boston Scientific stock for Q3 2023, down 1.4% quarter-over-quarter.
  • 98 funds opened new Boston Scientific positions in Q3 2023 and 94 closed out, a net change of +4 holders.
  • The largest Boston Scientific buyer in Q3 2023 was Fidelity Investments, an estimated $422M added.
  • The largest Boston Scientific seller in Q3 2023 was BlackRock, an estimated $429M sold.

Based on aggregated 13F filings for Q3 2023.